🚀 Dreaming of a career where you can make a difference? Discover the endless possibilities at NIAID with our #recruitment video. Whether you’re passionate about science, administration, or innovation, there is a place for you. Learn more from some of the dedicated public servants who make NIAID a great place to work: https://lnkd.in/e-sD2kX5 #PSRW #NIAIDCareers
National Institute of Allergy and Infectious Diseases (NIAID)
Government Administration
Rockville, Maryland 43,665 followers
Join NIAID and make a difference!
About us
This is the official LinkedIn account for the National Institute of Allergy and Infectious Diseases (NIAID). NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. Posted comments and images do not necessarily represent the views of NIAID, NIH. Comment Policy: www.niaid.nih.gov/global/comment-policy Privacy Policy: www.niaid.nih.gov/privacy Website: www.niaid.nih.gov
- Website
-
http://www.niaid.nih.gov
External link for National Institute of Allergy and Infectious Diseases (NIAID)
- Industry
- Government Administration
- Company size
- 1,001-5,000 employees
- Headquarters
- Rockville, Maryland
- Type
- Government Agency
Locations
-
Primary
9000 Rockville Pike
Rockville, Maryland 20892, US
Employees at National Institute of Allergy and Infectious Diseases (NIAID)
-
Gail Potter
Deputy Section Chief, Clinical Trials Research Section, at National Institute of Allergy and Infectious Diseases (NIAID)
-
Rodolfo Alarcon
Program Officer at National Institutes of Health/National Institute of Allergy and Infectious Diseases
-
Dave Chen
Senior Visualization Scientist at National Institute of Allergy and Infectious Diseases (NIAID)
-
Michael Mullins
Updates
-
Join #NIAID as a supervisory research training officer (RTO) in the Office of Research Training and Special Programs. The RTO will provide leadership for the institute's extramural training and #CareerDevelopment programs. Applications open 8/19/24. Learn more at https://go.nih.gov/C8LDEaV #NIAIDCareers
-
Malnutrition could lead to suppressed immune function with increased risk of #tuberculosis (TB). Nutritional monitoring and interventions are essential to detect, prevent and treat #TB effectively. Learn more: https://lnkd.in/dC82qfTi #NIAID
-
-
Applications close soon for the staff clinician position at the Laboratory of Allergic Diseases. Visit https://go.nih.gov/q7N21VD for more information and #ApplyNow. Applications close 8/15.
We are hiring 🔬! The Laboratory of Allergic Diseases (LAD) within the Division of Intramural Research, NIAID, seeks a candidate to serve as an allergy and immunology staff #clinician in clinical and translational research. In this role, the staff clinician will provide direct patient care in LAD clinical protocols at the NIH Clinical Center. As part of this position, the individual will also contribute to the development, management, and oversight of research on allergic diseases such as food allergy and atopic dermatitis in both adults and children and will mentor clinical staff and participate in the #NIH Clinical Center Allergy and Immunology Consultation Service, as well as train fellows in the Allergy and Immunology Clinical Fellowship Program. Applications close 8/15. Learn more and #ApplyNow at https://go.nih.gov/q7N21VD #NIAID #Research #JobOpening
Staff Clinician–Laboratory of Allergic Diseases
niaid.nih.gov
-
NIAID is recruiting for a 3-year #postdoctoral fellowship position with shared lab placement between the Prion Cell Biology Unit, located at NIAID’s Rocky Mountain Laboratories (RML) in Hamilton, Montana (1 year), and the Experimental Immunotherapeutics Unit (EIU), located at the NIH Clinical Center in Bethesda, Maryland (2 years). Learn more and #ApplyNow at https://go.nih.gov/upg2Ha0 #NIAIDCareers #NIAIDTraining
Postdoctoral Intramural Research Fellowship Position Available
niaid.nih.gov
-
Congratulations to Dr. June Kwon-Chung on being elected to the National Academy of Sciences!
Dr. June Kwon-Chung knew from a young age that she wanted to become a scientist. Almost six decades after she arrived at The National Institutes of Health in 1966 as a Fogarty International Fellow, she was elected to the National Academy of Sciences for her groundbreaking research on fungal diseases. Learn more about the National Institute of Allergy and Infectious Diseases (NIAID)'s Dr. Kwon-Chung: https://go.nih.gov/DGj4ZJ7 #NIH_IRP #fungaldiseases
-
-
Viral #hepatitis affects the lives of about one in twenty people in the world, resulting in over a million deaths each year. NIAID is working on many ways to prevent and treat the different types of hepatitis, including the development of vaccines and improved therapeutics and diagnostics. July 28 is observed annually as #WorldHepatitisDay, providing an opportunity to reflect on the impact of hepatitis on global health and focus on strategies to reduce its burden. To observe World Hepatitis Day, NIAID highlights recent advances researchers have made in these areas. Learn more at https://go.nih.gov/UpN6IiI
-
-
VIDEO: Check out the #NIAID blog for the latest updates from #AIDS2024 covering long-acting injectables, bi-directional learning, PACHA & more. Learn more: https://go.nih.gov/qlqsEpW Photo credit: HIVgov
-
-
National Institute of Allergy and Infectious Diseases (NIAID) reposted this
NIH’s approach to test therapeutic interventions for Long COVID is evolving. We will apply lessons learned from NIH Researching COVID to Enhance Recovery (RECOVER) studies and trials to develop a new program called RECOVER-Treating Long COVID (RECOVER-TLC). RECOVER-TLC will call upon the research community to help identify promising therapeutic approaches and study designs that will produce results that are needed by those affected by Long COVID. We need input from the research and Long COVID communities to ensure RECOVER-TLC can be a success. A kick-off meeting will be held September 23-25. Check back to this page for registration updates: https://lnkd.in/g4V4cUfT #LongCOVID #NIHRECOVER
-
-
Day 5 of #AIDS2024 #NIAID science snapshot for Friday, July 26: - Ensitrelvir showed antiviral activity, safety, & reduced time to #COVID19 symptom resolution in non-hospitalized adults but fared little better than placebo in time needed to fully resolve symptoms. - A #COVID19 vaccine study found people living with #HIV had high exposure to tuberculosis. The results demonstrate the need for #TB screening, surveillance, & collaboration with health experts for comprehensive HIV and TB care. - A study found that the bivalent #COVID19 #vaccine mRNA-1273 provided no additional protection compared to the monovalent vaccine for people living with or without #HIV when #Omicron variants were evolving. For full text abstracts, visit the AIDS 2024 program: https://lnkd.in/dfH9MuVC #vaccines
Conference Programme
programme.aids2024.org